search
Back to results

Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma

Primary Purpose

Ewing's Sarcoma

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Vincristine, Actinomycin-D, Ifosfamide
Sponsored by
King Faisal Specialist Hospital & Research Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ewing's Sarcoma

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with Ewing's Sarcoma

Sites / Locations

    Outcomes

    Primary Outcome Measures

    Efficacy

    Secondary Outcome Measures

    Full Information

    First Posted
    October 9, 2007
    Last Updated
    April 16, 2012
    Sponsor
    King Faisal Specialist Hospital & Research Center
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT00541411
    Brief Title
    Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2012
    Overall Recruitment Status
    Unknown status
    Study Start Date
    June 2003 (undefined)
    Primary Completion Date
    June 2013 (Anticipated)
    Study Completion Date
    June 2013 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    King Faisal Specialist Hospital & Research Center

    4. Oversight

    5. Study Description

    Brief Summary
    Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide combination chemotherapy in Ewing's Sarcoma

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Ewing's Sarcoma

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    10 (Anticipated)

    8. Arms, Groups, and Interventions

    Intervention Type
    Drug
    Intervention Name(s)
    Vincristine, Actinomycin-D, Ifosfamide
    Intervention Description
    Chemotherapy
    Primary Outcome Measure Information:
    Title
    Efficacy
    Time Frame
    overall

    10. Eligibility

    Sex
    All
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patients with Ewing's Sarcoma
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Muhammad Memon, MD
    Organizational Affiliation
    King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma

    We'll reach out to this number within 24 hrs